Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IT2-H53W3 | Human | Human Integrin alpha L beta 2 (ITGAL&ITGB2) Heterodimer Protein, His Tag&Tag Free |  |
|
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Lifitegrast | SAR-1119; SAR-1118; OJL-332; SPD-606; SHP-606 | Approved | Shire Development Llc | Xiidra | United States | Dry Eye Syndromes | Bausch And Lomb Inc | 2016-07-11 | Keratoconjunctivitis Sicca; Graft vs Host Disease; Dry Eye Syndromes; Conjunctivitis, Allergic; Diabetic macular oedema; Xerophthalmia | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Alintegimod | 7HP349; 7-HP-349; 7HP-349 | Phase 2 Clinical | 7 Hills Pharma LLC | Kidney Neoplasms; Solid tumours; Carcinoma, Renal Cell; Mismatch Repair Deficient Cancer; Skin Neoplasms; Neoplasms; Coronavirus Disease 2019 (COVID-19); Mesothelioma; Tuberculosis; Influenza, Human; Colorectal Neoplasms; Chagas Disease; Carcinoma, Hepatocellular; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
This web search service is supported by Google Inc.
A-Z
